首页 > 最新文献

Current Clinical Microbiology Reports最新文献

英文 中文
Emerging Roles of Modern Lifestyle Factors in Microbiome Stability and Functionality. 现代生活方式因素在微生物群稳定性和功能中的新作用。
IF 2.7 Q2 MICROBIOLOGY Pub Date : 2025-01-01 Epub Date: 2025-03-12 DOI: 10.1007/s40588-025-00242-3
Ye Yang, Maria C Hernandez, Siddhi Chitre, Christian Jobin

Purpose of review: It is now evident that the microorganisms living on and inside the human body modulate a myriad of host responses and activities. Particularly, the intestinal microbiota, which comprises diverse bacteria, fungi, archaea, viruses, and eukaryotic entities, forms a close relationship with the host. This relationship is essential for optimal biological function such as maintaining proper immune homeostasis, host metabolism, and prevention of pathogens colonization. The human gut microbiome is relatively stable after 3 years of age but is subjected to influences from diet, environment and lifestyle factors. This review covers recent findings on how lifestyle factors associated with modern society might affect the microbiome.

Recent findings: Modern lifestyle factors including circadian rhythm disruption, sleep deprivation, exercise and stress impact the gut bacterial community (bacteriome) composition and function. The resultant gut bacteriome changes contribute to host metabolism dysregulation, inflammatory diseases and cancer development associated with these lifestyle factors.

Summary: Lifestyle factors influence the gut bacteriome to modulate host health and disease risks. Understanding the mechanistic roles of diverse host-associated microorganisms played in lifestyle factors-associated disease risks holds the promise for developing novel approaches to alleviate the detrimental effects.

综述目的:现在很明显,生活在人体表面和体内的微生物调节了无数宿主的反应和活动。特别是肠道微生物群,包括各种细菌、真菌、古细菌、病毒和真核生物,与宿主形成密切的关系。这种关系对于维持适当的免疫稳态、宿主代谢和预防病原体定植等最佳生物学功能至关重要。人的肠道菌群在3岁以后相对稳定,但会受到饮食、环境和生活方式等因素的影响。这篇综述涵盖了与现代社会相关的生活方式因素如何影响微生物组的最新发现。最新发现:包括昼夜节律紊乱、睡眠不足、运动和压力在内的现代生活方式因素会影响肠道细菌群落(细菌组)的组成和功能。由此产生的肠道菌群变化导致宿主代谢失调、炎症性疾病和与这些生活方式因素相关的癌症发展。摘要:生活方式因素影响肠道菌群调节宿主健康和疾病风险。了解不同宿主相关微生物在生活方式因素相关疾病风险中的机制作用,有助于开发新的方法来减轻有害影响。
{"title":"Emerging Roles of Modern Lifestyle Factors in Microbiome Stability and Functionality.","authors":"Ye Yang, Maria C Hernandez, Siddhi Chitre, Christian Jobin","doi":"10.1007/s40588-025-00242-3","DOIUrl":"10.1007/s40588-025-00242-3","url":null,"abstract":"<p><strong>Purpose of review: </strong>It is now evident that the microorganisms living on and inside the human body modulate a myriad of host responses and activities. Particularly, the intestinal microbiota, which comprises diverse bacteria, fungi, archaea, viruses, and eukaryotic entities, forms a close relationship with the host. This relationship is essential for optimal biological function such as maintaining proper immune homeostasis, host metabolism, and prevention of pathogens colonization. The human gut microbiome is relatively stable after 3 years of age but is subjected to influences from diet, environment and lifestyle factors. This review covers recent findings on how lifestyle factors associated with modern society might affect the microbiome.</p><p><strong>Recent findings: </strong>Modern lifestyle factors including circadian rhythm disruption, sleep deprivation, exercise and stress impact the gut bacterial community (bacteriome) composition and function. The resultant gut bacteriome changes contribute to host metabolism dysregulation, inflammatory diseases and cancer development associated with these lifestyle factors.</p><p><strong>Summary: </strong>Lifestyle factors influence the gut bacteriome to modulate host health and disease risks. Understanding the mechanistic roles of diverse host-associated microorganisms played in lifestyle factors-associated disease risks holds the promise for developing novel approaches to alleviate the detrimental effects.</p>","PeriodicalId":45506,"journal":{"name":"Current Clinical Microbiology Reports","volume":"12 ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12826544/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146053789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bridging Ecology and Microbiomes: Applying Ecological Theories in Host-associated Microbial Ecosystems. 桥梁生态学和微生物组:应用生态学理论在宿主相关微生物生态系统。
IF 3.1 Q2 MICROBIOLOGY Pub Date : 2025-01-01 Epub Date: 2025-04-15 DOI: 10.1007/s40588-025-00246-z
Clara Flores, Sophie Millard, Anna M Seekatz

Purpose of review: This review explores the application of classical ecological theory to host-associated microbiomes during initial colonization, maintenance, and recovery. We discuss unique challenges of applying these theories to host-associated microbiomes and host factors to consider going forward.

Recent findings: Recent studies applying community ecology principles to host microbiomes continue to demonstrate a role for both selective and stochastic processes in shaping host-associated microbiomes. However, ecological frameworks developed to describe dynamics during homeostasis do not necessarily apply during diseased or highly perturbed states, where large variations can potentially lead to alternate stable states.

Summary: Despite providing valuable insights, the application of ecological theories to host-associated microbiomes has some unique challenges. The integration of host-specific factors, such as genotype or immune dynamics in ecological models or frameworks is crucial for understanding host microbiome assembly and stability, which could improve our ability to predict microbiome outcomes and improve host health.

综述目的:本文综述了经典生态学理论在宿主相关微生物群落的初始定植、维持和恢复过程中的应用。我们讨论了将这些理论应用于宿主相关微生物组和宿主因子的独特挑战,以考虑向前发展。最近的发现:最近的研究将群落生态学原理应用于宿主微生物组,继续证明了选择性和随机过程在形成宿主相关微生物组中的作用。然而,用于描述体内平衡期间动态的生态框架不一定适用于患病或高度扰动状态,在这些状态下,大的变化可能导致交替的稳定状态。摘要:尽管提供了有价值的见解,但生态学理论在宿主相关微生物组中的应用仍面临一些独特的挑战。在生态模型或框架中整合宿主特异性因素,如基因型或免疫动力学,对于理解宿主微生物组的组装和稳定性至关重要,这可以提高我们预测微生物组结果和改善宿主健康的能力。
{"title":"Bridging Ecology and Microbiomes: Applying Ecological Theories in Host-associated Microbial Ecosystems.","authors":"Clara Flores, Sophie Millard, Anna M Seekatz","doi":"10.1007/s40588-025-00246-z","DOIUrl":"10.1007/s40588-025-00246-z","url":null,"abstract":"<p><strong>Purpose of review: </strong>This review explores the application of classical ecological theory to host-associated microbiomes during initial colonization, maintenance, and recovery. We discuss unique challenges of applying these theories to host-associated microbiomes and host factors to consider going forward.</p><p><strong>Recent findings: </strong>Recent studies applying community ecology principles to host microbiomes continue to demonstrate a role for both selective and stochastic processes in shaping host-associated microbiomes. However, ecological frameworks developed to describe dynamics during homeostasis do not necessarily apply during diseased or highly perturbed states, where large variations can potentially lead to alternate stable states.</p><p><strong>Summary: </strong>Despite providing valuable insights, the application of ecological theories to host-associated microbiomes has some unique challenges. The integration of host-specific factors, such as genotype or immune dynamics in ecological models or frameworks is crucial for understanding host microbiome assembly and stability, which could improve our ability to predict microbiome outcomes and improve host health.</p>","PeriodicalId":45506,"journal":{"name":"Current Clinical Microbiology Reports","volume":"12 1","pages":"9"},"PeriodicalIF":3.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12000275/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144024081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-Read Sequencing for the Rapid Response to Infectious Diseases Outbreaks. 用于传染病暴发快速反应的长读测序。
IF 3.1 Q2 MICROBIOLOGY Pub Date : 2025-01-01 Epub Date: 2025-05-15 DOI: 10.1007/s40588-025-00247-y
Josephine B Oehler, Kaitlin Burns, Jeffrey Warner, Ulf Schmitz

Purpose of review: Long-read sequencing (LRS) has revolutionized pathogen surveillance by enabling real-time, high-fidelity genomic analysis critical for outbreak response. This review synthesizes recent breakthroughs in LRS, evaluating its impact on genomic epidemiology, metagenomics, and public health decision-making while addressing limitations and prospects for integrating LRS into global outbreak surveillance.

Recent findings: Unlike short-read sequencing, LRS-pioneered by Oxford Nanopore Technologies (ONT) and Pacific Biosciences (PacBio)-resolves complex genomic structures, antimicrobial resistance determinants, and transmission dynamics with unprecedented accuracy. The portability of some LRS devices has facilitated rapid pathogen identification in field settings, notably during the Ebola and COVID-19 pandemics. Despite advancements in basecalling algorithms and target enrichment, challenges including sequencing errors, computational bottlenecks, and cost barriers remain.

Summary: By critically evaluating recent findings and discussing future directions, this review highlights the importance of leveraging LRS for outbreak preparedness and response, equipping researchers and public health professionals with the knowledge necessary to navigate the complexities of modern infectious disease challenges.

综述目的:长读段测序(LRS)通过实现对疫情应对至关重要的实时、高保真基因组分析,彻底改变了病原体监测。本综述综合了LRS的最新突破,评估了其对基因组流行病学、宏基因组学和公共卫生决策的影响,同时探讨了将LRS纳入全球疫情监测的局限性和前景。最近的发现:与短读测序不同,lrs——由牛津纳米孔技术公司(ONT)和太平洋生物科学公司(PacBio)开创——以前所未有的准确性解决了复杂的基因组结构、抗菌素耐药性决定因素和传播动力学。一些LRS设备的便携性有助于在现场环境中快速识别病原体,特别是在埃博拉和COVID-19大流行期间。尽管在基调用算法和目标丰富方面取得了进步,但包括测序错误、计算瓶颈和成本障碍在内的挑战仍然存在。摘要:通过批判性地评估最近的发现和讨论未来的方向,本综述强调了利用LRS进行疫情准备和应对的重要性,为研究人员和公共卫生专业人员提供必要的知识,以应对现代传染病挑战的复杂性。
{"title":"Long-Read Sequencing for the Rapid Response to Infectious Diseases Outbreaks.","authors":"Josephine B Oehler, Kaitlin Burns, Jeffrey Warner, Ulf Schmitz","doi":"10.1007/s40588-025-00247-y","DOIUrl":"10.1007/s40588-025-00247-y","url":null,"abstract":"<p><strong>Purpose of review: </strong>Long-read sequencing (LRS) has revolutionized pathogen surveillance by enabling real-time, high-fidelity genomic analysis critical for outbreak response. This review synthesizes recent breakthroughs in LRS, evaluating its impact on genomic epidemiology, metagenomics, and public health decision-making while addressing limitations and prospects for integrating LRS into global outbreak surveillance.</p><p><strong>Recent findings: </strong>Unlike short-read sequencing, LRS-pioneered by Oxford Nanopore Technologies (ONT) and Pacific Biosciences (PacBio)-resolves complex genomic structures, antimicrobial resistance determinants, and transmission dynamics with unprecedented accuracy. The portability of some LRS devices has facilitated rapid pathogen identification in field settings, notably during the Ebola and COVID-19 pandemics. Despite advancements in basecalling algorithms and target enrichment, challenges including sequencing errors, computational bottlenecks, and cost barriers remain.</p><p><strong>Summary: </strong>By critically evaluating recent findings and discussing future directions, this review highlights the importance of leveraging LRS for outbreak preparedness and response, equipping researchers and public health professionals with the knowledge necessary to navigate the complexities of modern infectious disease challenges.</p>","PeriodicalId":45506,"journal":{"name":"Current Clinical Microbiology Reports","volume":"12 1","pages":"10"},"PeriodicalIF":3.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12081579/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144095357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SARS-CoV-2 Resistance to Small Molecule Inhibitors. SARS-CoV-2 对小分子抑制剂的抗药性。
IF 3.1 Q2 MICROBIOLOGY Pub Date : 2024-09-01 Epub Date: 2024-06-24 DOI: 10.1007/s40588-024-00229-6
Uxua Modrego Lopez, Md Mehedi Hasan, Brandon Havranek, Shahidul M Islam

Purpose of the review: SARS-CoV-2 undergoes genetic mutations like many other viruses. Some mutations lead to the emergence of new Variants of Concern (VOCs), affecting transmissibility, illness severity, and the effectiveness of antiviral drugs. Continuous monitoring and research are crucial to comprehend variant behavior and develop effective response strategies, including identifying mutations that may affect current drug therapies.

Recent findings: Antiviral therapies such as Nirmatrelvir and Ensitrelvir focus on inhibiting 3CLpro, whereas Remdesivir, Favipiravir, and Molnupiravir target nsp12, thereby reducing the viral load. However, the emergence of resistant mutations in 3CLpro and nsp12 could impact the efficiency of these small molecule drug therapeutics.

Summary: This manuscript summarizes mutations in 3CLpro and nsp12, which could potentially reduce the efficacy of drugs. Additionally, it encapsulates recent advancements in small molecule antivirals targeting SARS-CoV-2 viral proteins, including their potential for developing resistance against emerging variants.

审查的目的:与许多其他病毒一样,SARS-CoV-2 也会发生基因突变。有些变异会导致新的关注变异体(VOC)的出现,影响传播性、疾病严重程度和抗病毒药物的有效性。持续监测和研究对于理解变异行为和制定有效的应对策略至关重要,包括确定可能影响当前药物疗法的变异:最近的研究结果:Nirmatrelvir 和 Ensitrelvir 等抗病毒疗法主要抑制 3CLpro,而 Remdesivir、Favipiravir 和 Molnupiravir 则针对 nsp12,从而降低病毒载量。然而,3CLpro 和 nsp12 耐药突变的出现可能会影响这些小分子药物疗法的疗效。摘要:本手稿总结了 3CLpro 和 nsp12 的突变,这些突变可能会降低药物的疗效。此外,它还概括了针对 SARS-CoV-2 病毒蛋白的小分子抗病毒药物的最新进展,包括它们对新出现的变体产生抗药性的可能性。
{"title":"SARS-CoV-2 Resistance to Small Molecule Inhibitors.","authors":"Uxua Modrego Lopez, Md Mehedi Hasan, Brandon Havranek, Shahidul M Islam","doi":"10.1007/s40588-024-00229-6","DOIUrl":"10.1007/s40588-024-00229-6","url":null,"abstract":"<p><strong>Purpose of the review: </strong>SARS-CoV-2 undergoes genetic mutations like many other viruses. Some mutations lead to the emergence of new Variants of Concern (VOCs), affecting transmissibility, illness severity, and the effectiveness of antiviral drugs. Continuous monitoring and research are crucial to comprehend variant behavior and develop effective response strategies, including identifying mutations that may affect current drug therapies.</p><p><strong>Recent findings: </strong>Antiviral therapies such as Nirmatrelvir and Ensitrelvir focus on inhibiting 3CLpro, whereas Remdesivir, Favipiravir, and Molnupiravir target nsp12, thereby reducing the viral load. However, the emergence of resistant mutations in 3CLpro and nsp12 could impact the efficiency of these small molecule drug therapeutics.</p><p><strong>Summary: </strong>This manuscript summarizes mutations in 3CLpro and nsp12, which could potentially reduce the efficacy of drugs. Additionally, it encapsulates recent advancements in small molecule antivirals targeting SARS-CoV-2 viral proteins, including their potential for developing resistance against emerging variants.</p>","PeriodicalId":45506,"journal":{"name":"Current Clinical Microbiology Reports","volume":"11 3","pages":"127-139"},"PeriodicalIF":3.1,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11573241/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142668815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating Genomic Data with the Development of CRISPR-Based Point-of-Care-Testing for Bacterial Infections. 将基因组数据与开发基于 CRISPR 的细菌感染护理点检测相结合。
IF 3.1 Q2 MICROBIOLOGY Pub Date : 2024-01-01 Epub Date: 2024-10-15 DOI: 10.1007/s40588-024-00236-7
Thanyapat Wanitchanon, Claire Chewapreecha, Chayasith Uttamapinant

Purpose of review: Bacterial infections and antibiotic resistance contribute to global mortality. Despite many infections being preventable and treatable, the lack of reliable and accessible diagnostic tools exacerbates these issues. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)-based diagnostics has emerged as a promising solution. However, the development of CRISPR diagnostics has often occurred in isolation, with limited integration of genomic data to guide target selection. In this review, we explore the synergy between bacterial genomics and CRISPR-based point-of-care tests (POCT), highlighting how genomic insights can inform target selection and enhance diagnostic accuracy.

Recent findings: We review recent advances in CRISPR-based technologies, focusing on the critical role of target sequence selection in improving the sensitivity of CRISPR-based diagnostics. Additionally, we examine the implementation of these technologies in resource-limited settings across Asia and Africa, presenting successful case studies that demonstrate their potential.

Summary: The integration of bacterial genomics with CRISPR technology offers significant promise for the development of effective point-of-care diagnostics.

审查目的:细菌感染和抗生素耐药性导致全球死亡率上升。尽管许多感染是可以预防和治疗的,但由于缺乏可靠和方便的诊断工具,这些问题变得更加严重。基于 CRISPR(Clustered Regularly Interspaced Short Palindromic Repeats)的诊断方法已成为一种前景广阔的解决方案。然而,CRISPR 诊断技术的开发往往是孤立进行的,对基因组数据的整合有限,无法指导目标选择。在这篇综述中,我们探讨了细菌基因组学与基于CRISPR的床旁检测(POCT)之间的协同作用,重点介绍了基因组学见解如何为目标选择提供信息并提高诊断准确性:我们回顾了基于 CRISPR 的技术的最新进展,重点关注目标序列选择在提高基于 CRISPR 的诊断灵敏度方面的关键作用。摘要:细菌基因组学与 CRISPR 技术的整合为开发有效的护理点诊断技术带来了巨大的希望。
{"title":"Integrating Genomic Data with the Development of CRISPR-Based Point-of-Care-Testing for Bacterial Infections.","authors":"Thanyapat Wanitchanon, Claire Chewapreecha, Chayasith Uttamapinant","doi":"10.1007/s40588-024-00236-7","DOIUrl":"https://doi.org/10.1007/s40588-024-00236-7","url":null,"abstract":"<p><strong>Purpose of review: </strong>Bacterial infections and antibiotic resistance contribute to global mortality. Despite many infections being preventable and treatable, the lack of reliable and accessible diagnostic tools exacerbates these issues. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)-based diagnostics has emerged as a promising solution. However, the development of CRISPR diagnostics has often occurred in isolation, with limited integration of genomic data to guide target selection. In this review, we explore the synergy between bacterial genomics and CRISPR-based point-of-care tests (POCT), highlighting how genomic insights can inform target selection and enhance diagnostic accuracy.</p><p><strong>Recent findings: </strong>We review recent advances in CRISPR-based technologies, focusing on the critical role of target sequence selection in improving the sensitivity of CRISPR-based diagnostics. Additionally, we examine the implementation of these technologies in resource-limited settings across Asia and Africa, presenting successful case studies that demonstrate their potential.</p><p><strong>Summary: </strong>The integration of bacterial genomics with CRISPR technology offers significant promise for the development of effective point-of-care diagnostics.</p>","PeriodicalId":45506,"journal":{"name":"Current Clinical Microbiology Reports","volume":"11 4","pages":"241-258"},"PeriodicalIF":3.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11541280/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142629720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intimate Relationship Between Stress and Human Alpha‑Herpes Virus 1 (HSV‑1) Reactivation from Latency. 应激与人类甲型疱疹病毒1型(HSV-1)潜伏期再激活的密切关系
IF 5.2 Q2 MICROBIOLOGY Pub Date : 2023-12-01 Epub Date: 2023-07-27 DOI: 10.1007/s40588-023-00202-9
Clinton Jones

Purpose of review: Numerous studies concluded stress (acute, episodic acute, or chronic) increases the incidence of human alpha-herpes virus 1 (HSV-1) reactivation from latency in neurons. This review will summarize how stress stimulates viral gene expression, replication, and reactivation from latency.

Recent findings: Stress (capital S) stress-mediated activation of the glucocorticoid receptor (GR) accelerates reactivation from latency, whereas a corticosteroid-specific antagonist impairs viral replication and reactivation from latency. GR and specific stress-induced cellular transcription factors also stimulate viral promoters that drive expression of key viral transcriptional regulators: infected cell protein 0 (ICP0), ICP4, ICP27 and viral tegument protein (VP16). Hence, GR is predicted to initially stimulate viral gene expression. GR-mediated immune-inhibitory functions are also predicted to enhance viral replication and viral spread.

Summary: Identifying cellular factors and viral regulatory proteins that trigger reactivation from latency in neurons may provide new therapeutic strategies designed to reduce the incidence of reactivation from latency.

综述的目的:大量研究认为,压力(急性、偶发性急性或慢性)会增加人类α-疱疹病毒1(HSV-1)从神经元潜伏期重新激活的发生率。本综述将总结压力是如何刺激病毒基因表达、复制和从潜伏期重新激活的:最近的研究发现:应激(大写字母 S)介导的糖皮质激素受体(GR)激活可加速潜伏期病毒的重新激活,而皮质激素特异性拮抗剂则会损害病毒复制和潜伏期病毒的重新激活。GR和特定压力诱导的细胞转录因子也会刺激病毒启动子,从而驱动关键病毒转录调节因子的表达:感染细胞蛋白0(ICP0)、ICP4、ICP27和病毒外壳蛋白(VP16)。因此,预计 GR 最初会刺激病毒基因的表达。小结:确定引发神经元潜伏期再活化的细胞因素和病毒调控蛋白可能会提供新的治疗策略,以降低潜伏期再活化的发生率。
{"title":"Intimate Relationship Between Stress and Human Alpha‑Herpes Virus 1 (HSV‑1) Reactivation from Latency.","authors":"Clinton Jones","doi":"10.1007/s40588-023-00202-9","DOIUrl":"10.1007/s40588-023-00202-9","url":null,"abstract":"<p><strong>Purpose of review: </strong>Numerous studies concluded stress (acute, episodic acute, or chronic) increases the incidence of human alpha-herpes virus 1 (HSV-1) reactivation from latency in neurons. This review will summarize how stress stimulates viral gene expression, replication, and reactivation from latency.</p><p><strong>Recent findings: </strong>Stress (capital S) stress-mediated activation of the glucocorticoid receptor (GR) accelerates reactivation from latency, whereas a corticosteroid-specific antagonist impairs viral replication and reactivation from latency. GR and specific stress-induced cellular transcription factors also stimulate viral promoters that drive expression of key viral transcriptional regulators: infected cell protein 0 (ICP0), ICP4, ICP27 and viral tegument protein (VP16). Hence, GR is predicted to initially stimulate viral gene expression. GR-mediated immune-inhibitory functions are also predicted to enhance viral replication and viral spread.</p><p><strong>Summary: </strong>Identifying cellular factors and viral regulatory proteins that trigger reactivation from latency in neurons may provide new therapeutic strategies designed to reduce the incidence of reactivation from latency.</p>","PeriodicalId":45506,"journal":{"name":"Current Clinical Microbiology Reports","volume":"1 1","pages":"236-245"},"PeriodicalIF":5.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10764003/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48421532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bacterial and Fungal Keratitis: Current Trends in Its Diagnosis and Management 细菌性和真菌性角膜炎:诊断和管理的当前趋势
IF 5.2 Q2 MICROBIOLOGY Pub Date : 2023-11-15 DOI: 10.1007/s40588-023-00210-9
Surya Prakash Sharma, Sujata Dwivedi, Sunil Kumar, K. Dhama, A. K. Sharma
{"title":"Bacterial and Fungal Keratitis: Current Trends in Its Diagnosis and Management","authors":"Surya Prakash Sharma, Sujata Dwivedi, Sunil Kumar, K. Dhama, A. K. Sharma","doi":"10.1007/s40588-023-00210-9","DOIUrl":"https://doi.org/10.1007/s40588-023-00210-9","url":null,"abstract":"","PeriodicalId":45506,"journal":{"name":"Current Clinical Microbiology Reports","volume":"13 2","pages":"266 - 278"},"PeriodicalIF":5.2,"publicationDate":"2023-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139271310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Engineered Therapeutic Antibody Against SARS-CoV-2 针对SARS-CoV-2的工程化治疗性抗体
Q2 MICROBIOLOGY Pub Date : 2023-11-14 DOI: 10.1007/s40588-023-00212-7
Monrat Chulanetra
{"title":"Engineered Therapeutic Antibody Against SARS-CoV-2","authors":"Monrat Chulanetra","doi":"10.1007/s40588-023-00212-7","DOIUrl":"https://doi.org/10.1007/s40588-023-00212-7","url":null,"abstract":"","PeriodicalId":45506,"journal":{"name":"Current Clinical Microbiology Reports","volume":"64 4","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134991322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Status of Drug Discovery in Wetlands Through a Lens of Bioprospecting for New Antimicrobials Being Produced by Microorganisms 从微生物产生的新型抗菌素的生物勘探角度看湿地药物发现的现状
Q2 MICROBIOLOGY Pub Date : 2023-11-08 DOI: 10.1007/s40588-023-00209-2
Bojana Stekovic, Karl Anderson, Delainey Lancaster, Evelyn Stuck, Tsebaot Getachew, Venugopal Mukku, Brian J. Dingmann
{"title":"Status of Drug Discovery in Wetlands Through a Lens of Bioprospecting for New Antimicrobials Being Produced by Microorganisms","authors":"Bojana Stekovic, Karl Anderson, Delainey Lancaster, Evelyn Stuck, Tsebaot Getachew, Venugopal Mukku, Brian J. Dingmann","doi":"10.1007/s40588-023-00209-2","DOIUrl":"https://doi.org/10.1007/s40588-023-00209-2","url":null,"abstract":"","PeriodicalId":45506,"journal":{"name":"Current Clinical Microbiology Reports","volume":"9 9","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135392122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Porin-Mediated Carbapenem Resistance in Klebsiella pneumoniae: an Alarming Threat to Global Health 肺炎克雷伯菌中孔蛋白介导的碳青霉烯耐药:对全球健康的惊人威胁
Q2 MICROBIOLOGY Pub Date : 2023-11-04 DOI: 10.1007/s40588-023-00211-8
Indrani Gogoi, Minakshi Puzari, Pankaj Chetia
{"title":"Porin-Mediated Carbapenem Resistance in Klebsiella pneumoniae: an Alarming Threat to Global Health","authors":"Indrani Gogoi, Minakshi Puzari, Pankaj Chetia","doi":"10.1007/s40588-023-00211-8","DOIUrl":"https://doi.org/10.1007/s40588-023-00211-8","url":null,"abstract":"","PeriodicalId":45506,"journal":{"name":"Current Clinical Microbiology Reports","volume":"35 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135773460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current Clinical Microbiology Reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1